COR - Cencora - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03073E1055
Pharmaceuticals, Healthcare Products, Medical Supplies, Vaccines, Diagnostics
Cencora Inc. is a leading pharmaceutical sourcing and distribution company that operates through two main segments: U.S. Healthcare Solutions and International Healthcare Solutions.
The U.S. Healthcare Solutions segment is a comprehensive healthcare partner, providing a wide range of products and services to various healthcare providers, including acute care hospitals, health systems, retail pharmacies, mail order pharmacies, medical clinics, and long-term care facilities. The company distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment, as well as offers pharmacy management, staffing, and consulting services. Additionally, it provides supply management software, packaging solutions, clinical trial support, product post-approval, and commercialization support services to its customers.
Furthermore, this segment offers data analytics, outcomes research, and additional services to biotechnology and pharmaceutical manufacturers. It also distributes products to the companion animal and production animal markets, including pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients. Moreover, the company provides sales force services to manufacturers and distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products to healthcare providers, including physicians specializing in oncology and other disease states.
The International Healthcare Solutions segment focuses on international pharmaceutical wholesale and related services, distributing pharmaceuticals, healthcare products, and services to pharmacies, doctors, health centers, and hospitals primarily in Europe. The company also provides global commercialization services and specialty transportation and logistics services for the biopharmaceutical industry.
With a rich history dating back to 2001, Cencora Inc. was formerly known as AmerisourceBergen Corporation and changed its name to Cencora Inc. in August 2023. The company is headquartered in Conshohocken, Pennsylvania, and can be found online at https://www.cencora.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
COR Stock Overview
Market Cap in USD | 43,951m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC SubIndustry | Health Care Distributors |
TER | 0.00% |
IPO / Inception | 1995-04-04 |
COR Stock Ratings
Growth 5y | 92.8 |
Fundamental | 46.0 |
Dividend | 50.6 |
Rel. Performance vs Sector | 0.22 |
Analysts | 4.00/5 |
Fair Price Momentum | 266.06 USD |
Fair Price DCF | 487.56 USD |
COR Dividends
Dividend Yield 12m | 0.86% |
Yield on Cost 5y | 2.54% |
Dividends CAGR 5y | 4.20% |
Payout Consistency | 99.6% |
COR Growth Ratios
Growth 12m | 26.43% |
Growth Correlation 12m | 55.2% |
Growth Correlation 3m | -51% |
CAGR 5y | 24.08% |
CAGR/Mean DD 5y | 4.76 |
Sharpe Ratio 12m | 1.26 |
Alpha vs SP500 12m | 0.96 |
Beta vs SP500 5y weekly | 0.58 |
ValueRay RSI | 75.03 |
Volatility GJR Garch 1y | 21.78% |
Price / SMA 50 | 1.81% |
Price / SMA 200 | 2.6% |
Current Volume | 847.8k |
Average Volume 20d | 1534.1k |
External Links for COR Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 22, 2024, the stock is trading at USD 236.54 with a total of 847,779 shares traded.
Over the past week, the price has changed by +5.22%, over one month by +3.70%, over three months by +5.49% and over the past year by +26.30%.
According to ValueRays Forecast Model, COR Cencora will be worth about 290.2 in October 2025. The stock is currently trading at 236.54. This means that the stock has a potential upside of +22.68%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 261.1 | 10.4 |
Analysts Target Price | 209.7 | -11.4 |
ValueRay Target Price | 290.2 | 22.7 |